NM_001316764.3:c.1231G>A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001316764.3(C2orf81):​c.1231G>A​(p.Gly411Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,546,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

C2orf81
NM_001316764.3 missense

Scores

16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -2.71
Variant links:
Genes affected
C2orf81 (HGNC:34350): (chromosome 2 open reading frame 81) Predicted to be involved in regulation of transcription, DNA-templated. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.041841745).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C2orf81NM_001316764.3 linkc.1231G>A p.Gly411Ser missense_variant Exon 3 of 3 ENST00000684111.1 NP_001303693.1 A0A804HJ35
C2orf81NM_001145054.2 linkc.1150G>A p.Gly384Ser missense_variant Exon 4 of 4 NP_001138526.1 G3XAA6
C2orf81NM_001316765.2 linkc.1084G>A p.Gly362Ser missense_variant Exon 3 of 3 NP_001303694.1
C2orf81NM_001316766.2 linkc.946G>A p.Gly316Ser missense_variant Exon 2 of 2 NP_001303695.1 A0A1W2PQG2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C2orf81ENST00000684111.1 linkc.1231G>A p.Gly411Ser missense_variant Exon 3 of 3 NM_001316764.3 ENSP00000507340.1 A0A804HJ35
ENSG00000159239ENST00000517883.2 linkn.946G>A non_coding_transcript_exon_variant Exon 2 of 5 5 ENSP00000431103.2 E5RJQ4

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
152232
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000220
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000543
AC:
8
AN:
147232
Hom.:
0
AF XY:
0.0000635
AC XY:
5
AN XY:
78768
show subpopulations
Gnomad AFR exome
AF:
0.000279
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000716
Gnomad NFE exome
AF:
0.0000891
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000147
AC:
205
AN:
1394018
Hom.:
0
Cov.:
32
AF XY:
0.000146
AC XY:
100
AN XY:
687130
show subpopulations
Gnomad4 AFR exome
AF:
0.0000635
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000168
Gnomad4 NFE exome
AF:
0.000174
Gnomad4 OTH exome
AF:
0.000139
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
152232
Hom.:
0
Cov.:
33
AF XY:
0.0000941
AC XY:
7
AN XY:
74378
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000220
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000135
Hom.:
0
Bravo
AF:
0.0000907
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000448
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 22, 2021
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.1150G>A (p.G384S) alteration is located in exon 4 (coding exon 4) of the C2orf81 gene. This alteration results from a G to A substitution at nucleotide position 1150, causing the glycine (G) at amino acid position 384 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.25
DANN
Benign
0.73
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.012
N
LIST_S2
Benign
0.56
T;T;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.042
T;T;T
MetaSVM
Benign
-1.0
T
PROVEAN
Benign
-0.070
.;.;N
REVEL
Benign
0.0050
Sift
Benign
0.52
.;.;T
Sift4G
Benign
0.65
T;.;T
Polyphen
0.017
.;.;B
Vest4
0.061
MVP
0.014
ClinPred
0.077
T
GERP RS
-3.7
Varity_R
0.033
gMVP
0.098

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs762292786; hg19: chr2-74642073; API